Congress: Translational research in HNSCC: New challenges for future therapies
Jornades
Sala d’actes de la planta 10 de l’Hospital General —
Veure al mapa
02/12/2024
al
03/12/2024
02/12/2024 -- De 09:00h a 17:00h
02/12/2024 -- De 09:00h a 17:00h
Organitza
:
Drs. David Virós (Head of the department of otorhinolaryngology, HUVH) and Matilde E. LLeonart (Head of the Translational Research in Cancer Stem Cells laboratory, VHIR)
Modalitat: In-person
https://aula.vallhebron.com/index.php?go=info_cursos&curso=696
Head and neck cancer is an understudied disease with a high relapse and mortality rate. Therapeutic modalities have not significantly improved since the last 40 years. Even though immunotherapy is providing promising results, currently it is only applicable to metastatic patients. Finding new therapies for HNSCC patients is the main objective and challenge for basic and clinical researchers. With the idea of promoting new challenges and future applications for medium term applicability to HNSCC patients.